Another potential blockbuster just joined AbbVie's drug portfolio.
At just 29, Michael J. Fox faced the life-altering diagnosis of Parkinson's disease, which ignited his passion for advocacy.
The data add to the evidence behind ecopipam as the drug awaits a decision from the US Food and Drug Administration under ...
Doctors initially told the boy's parents not to worry. But they pressed for years until a rare diagnosis became clear.
Everyone knows a bad night’s sleep can ruin your day—and that routinely struggling to fall and stay asleep can profoundly ...
OBOXMA on MSN
Former Habs Lyle Odelein dead at 58
The year 2026 was marked by the passing of many personalities who left a lasting mark on our society. Artists, creators, ...
Ecopipam is a first-in-class investigational therapy designed to block dopamine signaling at the D1 receptor. D1 receptor hypersensitivity may contribute to repetitive and compulsive behaviors ...
Chad Lowe's 17-year-old daughter Mabel has shared a touching tribute for her younger sister Fiona Hepler Lowe after her death ...
Chad Lowe's 17-year-old daughter, Mabel Lowe, shared a touching tribute for her 13-year-old sister, Fiona Hepler Lowe, who ...
Is it possible to receive disability group II with multiple diseases and what important points to consider during the ...
Opinion
Griffin: Measles, Dengue, and Ebola Deaths Show What Happens When Policy Retreats From Vaccines
Infectious disease physician Daniel Griffin, speaking on This Week in Virology, delivered a clinical update that reads as a chronicle of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results